Biocompatibility and bone formation of flexible, cotton wool-like PLGA/calcium phosphate nanocomposites in sheep by Schneider, Oliver D et al.
 The Open Orthopaedics Journal, 2011, 5, 63-71 63 
 
 1874-3250/11 2011 Bentham Open 
Open Access 
Biocompatibility and Bone Formation of Flexible, Cotton Wool-like 
PLGA/Calcium Phosphate Nanocomposites in Sheep 
Oliver D. Schneider
1
, Dirk Mohn
1
, Roland Fuhrer
1
, Karina Klein
2
, Käthi Kämpf
2
, Katja M.R. Nuss
2
, 
Michèle Sidler
2
, Katalin Zlinszky
2
, Brigitte von Rechenberg
2,3
 and Wendelin J. Stark
*,1,3
 
1
Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 
Zurich, Switzerland 
2
Musculoskeletal Research Unit (MSRU), Equine Hospital, University of Zurich, 8057 Zurich, Switzerland 
3
Center of Applied Biotechnology and Molecular Medicine (CABMM), Equine Hospital, Vetsuisse Faculty, 8057 Zurich, 
Switzerland 
Abstract: Background: The purpose of this preliminary study was to assess the in vivo performance of synthetic, cotton 
wool-like nanocomposites consisting of a biodegradable poly(lactide-co-glycolide) fibrous matrix and containing either 
calcium phosphate nanoparticles (PLGA/CaP 60:40) or silver doped CaP nanoparticles (PLGA/Ag-CaP 60:40). Besides 
its extraordinary in vitro bioactivity the latter biomaterial (0.4 wt% total silver concentration) provides additional 
antimicrobial properties for treating bone defects exposed to microorganisms. 
Materials and Methods: Both flexible artificial bone substitutes were implanted into totally 16 epiphyseal and 
metaphyseal drill hole defects of long bone in sheep and followed for 8 weeks. Histological and histomorphological 
analyses were conducted to evaluate the biocompatibility and bone formation applying a score system. The influence of 
silver on the in vivo performance was further investigated. 
Results: Semi-quantitative evaluation of histology sections showed for both implant materials an excellent 
biocompatibility and bone healing with no resorption in the adjacent bone. No signs of inflammation were detectable, 
either macroscopically or microscopically, as was evident in 5 ?m plastic sections by the minimal amount of 
inflammatory cells. The fibrous biomaterials enabled bone formation directly in the centre of the former defect. The area 
fraction of new bone formation as determined histomorphometrically after 8 weeks implantation was very similar with 
20.5 ± 11.2 % and 22.5 ± 9.2 % for PLGA/CaP and PLGA/Ag-CaP, respectively. 
Conclusions: The cotton wool-like bone substitute material is easily applicable, biocompatible and might be beneficial in 
minimal invasive surgery for treating bone defects. 
Keywords: In vivo, bone regeneration, flexible, scaffold, silver. 
1. INTRODUCTION 
 Every year, more than one million bone grafts are needed 
worldwide. The golden standard for orthopaedic cure is still 
auto- and allografting [1, 2]. However, this method suffers 
from limited graft availability, the requirement of a second 
surgery and a serious risk of pain and infection at the donor-
site [3-5]. Therefore, synthetic bone replacements are an attr-
active alternative, and should enable fast bone regeneration 
and show good handling properties during surgical appli-
cation, especially in minimally invasive surgery. Addition-
ally, a synthetic biomaterial should be bioresorbable and 
ideally exhibit antimicrobial properties to counteract 
postoperative infections. In this regard, silver is known for 
thousands of years for its antimicrobial properties with low 
toxicity to human cells [6, 7] and has been applied in wound 
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dressings [8] or in bone cements [9]. In terms of bioactivity, 
specific materials such as tricalcium phosphate (TCP) or 
bioactive glasses are synthetic materials clinically used in 
orthopaedics [10-12] in the form of blocks, cements or 
granules. They are osteoconductive, enhance osteoblast 
differentiation and can induce strong bonding to bone. 
 However, surgery is often complicated by the brittleness 
(of granules) and the lack of possibility to shape the implant 
material during the operation. Flexibility can be obtained by 
incorporating ceramics as fillers in biodegradable polymers 
where it may improve mechanical properties and 
processability [13, 14]. Poly(lactide-co-glycolide) (PLGA) is 
a hydrolytically degradable and biocompatible polymer [15] 
and has been approved by the Food and Drug Administration 
(FDA) for drug delivery and in nerve- and bone 
regeneration. Electrospinning has turned out as a suitable 
method to create elastic, open structured, highly porous 
networks of polymer fibres [16, 17] which enable cell 
attachment, cell migration and nutrient transport [18] in a 
scaffold. It has been recently shown that an electrospun 
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biodegradable matrix can improve the regeneration of dense 
cortical bone in vivo [19]. 
 By using very fine powders (nanoparticles), a 
nanostructured surface can be induced in the scaffold and 
thus mimic the structure of natural bone with a significant 
enhancement of osteoblast activity [20-23] and protein 
adsorption [24]. Calcium phosphate (CaP) nanoparticles, in 
their amorphous state, can serve as a precursor for rapid 
hydroxyapatite formation [25, 26] inside the body just hours 
after implantation, as shown for films [27] and bone screws 
[28] where the mineral improved degradation and 
mechanical properties. We have recently prepared flexible 
PLGA/amorphous-CaP nanocomposites with a cotton wool-
like appearance (bone wool) and found efficient osteogenic 
differentiation of human mesenchymal stem cells [29], easy 
applicability and proper bone formation in calvarial defects 
in rabbits [30]. Optional silver doping resulted in enhanced 
antimicrobial properties against Escherichia coli [31] when 
compared to tetracycline controls. 
 The objective in the present study is a pre-clinical 
evaluation of such cotton wool-like scaffolds in non-load 
bearing bone defects (e.g. socket preservation; osteoporosis; 
sinus lift, etc). More specifically, we tested the in vivo 
performance using a drill hole defect model in the 
metaphysis and epiphysis of long bone in sheep following 
well established procedures [32]. The effect of silver on the 
biocompatibility and cellular reactions during bone 
regeneration was assessed through qualitative and semi-
quantitative histology after eight weeks implantation. 
Histomorphometrical analysis was performed to evaluate 
new bone formation and compared to earlier studies [33, 34] 
with the same drill hole defects left open (controls, no 
treatment) or filled with CaP cements or porous ?-TCP 
blocks (recently developed, modern treatments). 
2. MATERIALS AND METHODS 
2.1. Cotton Wool-like PLGA/CaP and PLGA/Ag-CaP 
Nanocomposites 
 X-ray diffraction (XRD)-amorphous calcium phosphate 
(CaP, Ca3(PO4)2) and silver calcium phosphate nanoparticles 
(Ag-CaP, 1 wt% Ag on CaP) were prepared by flame spray 
synthesis [35-38] and thoroughly characterized (see Suppl. 
material 1). Clinically approved poly(lactide-co-glycolide) 
(PLGA) was purchased from Boehringer Ingelheim with a 
copolymer ratio of 85:15 (Resomer® Sample MD Type RG) 
and with a weight and number average molecular weight of 
305’440 g/mol and 110’500 g/mol, respectively. PLGA/CaP 
60:40 and PLGA/Ag-CaP 60:40 (total silver concentration in 
scaffold = 0.4 wt%) scaffolds were fabricated by low-
temperature electrospinning [17] (see Suppl. material 1), 
portioned (109-134 mg) and UV-sterilized (50 W/m
2
, 90 
min). 
2.2. Animal Model in Sheep 
 Two female, white Swiss Alpine sheep with an age of 2.5 
years and a bodyweight of 43-46 kg served as experimental 
animals (sheep 3118 and sheep 3119). The animal study was 
conducted according to the Swiss Law of animal protection 
and welfare and was permitted through the official, Swiss 
authorities (permission # 74/2008). Prior to anaesthesia, the 
health status of the animals was checked. A standardized 
balanced anaesthetic protocol was used. After 24 h of 
fasting, premedication and sedation was achieved 
(Buprenorphine (Temgesic
®
, 0.01 mg/kg im, Essex Chemie 
AG, Switzerland); Xylazine (Rompun
®
 2%, 0.1 mg/kg im, 
Provet AG, Switzerland)). Anaesthesia was induced 
(Diazepam (Valium
®
, 0.1 mg/kg iv, Roche Pharma AG, 
Switzerland); Ketamine (Narketan 10
®
, 4 mg/kg iv, 
Vetoquinol AG, Switzerland); Propofol (Propofol
®
, 0.4 
mg/kg iv, Fresenius Kabi, Switzerland)) before general 
inhalation. Anaesthesia was maintained using isoflurane in 
100% oxygen via an appropriately sized breathing system 
and a constant rate infusion of Propofol (Propofol
®
, 
0.1mg/kg/h, Fresenius Kabi, Switzerland). Equine tetanus 
serum (Tetanus serum 3000 IU, Veternaria AG, 
Switzerland), Benzylpenicillin (Procain-Penicillin Streuli ad 
us. vet., 30’000 IU/kg, G. Streuli & Co AG; Switzerland), 
Gentamicin (Vetagent
® 
ad us. vet., 6 mg/kg, Veterinaria AG, 
Switzerland) and Carprofen (Rimadyl
®
, 4 mg/kg, Pfizer AG, 
Switzerland) were given prophylactically for 3 days to avoid 
peri- and postoperative infection, pain and acute 
inflammation. 
 The sheep were placed in left or right lateral recumbency 
on the operating table. Routinely, a lateral surgical approach 
to the bone was used. Totally 8 drill hole defects (diameter = 
8 mm, depth = 13 mm) were created with a drill bit in the 
distal (di) epiphysis and proximal (pr) metaphysis of the 
right and left humerus (hu) and femur (fe) as described in 
detail by Nuss et al. [32]. The bone cavities were carefully 
washed to eliminate bone debris and dried before filling 
them with PLGA/CaP and PLGA/Ag-CaP scaffolds (~ 109-
134 mg). The wound was closed and the skin was stapled. 
After recovery the sheep were kept in stalls with free access 
to food and water. The sheep were sacrificed at 8 weeks after 
surgery. 
2.3. Macroscopic and Radiographic Analysis 
 The bone samples were harvested directly after slaughter 
of sheep. The defects were macroscopically evaluated with 
respect to filling of the defect with bone, respectively fibrous 
tissue and signs of inflammation in the adjacent tissue. For 
detailed radiographs, bone specimens were cut perpendicular 
to the bone defect using a band saw, and bone blocks were 
documented with a Faxitron (55 kV, 5 s, Faxitron Cabinet X-
ray system, Model MX-20). Contact microradiographs (400 
?m) (Faxitron, X-ray System) were created with a high 
resolution film (X-OMAT MA film, Kodak Film, France) 
and used to compare with histological grinding sections. 
2.4. Histology 
 Histology sections of extracted bone samples were 
prepared as described by Apelt et al. [33]. Briefly, the drill 
hole defects were fixed in 4% paraformaldehyde for 2 
weeks, dehydrated in increasing grades of ethanol (50-100%) 
before defatting with xylene. Next, embedding was 
performed by placing the bone samples in acrylic resin 
(Histo-Dur
®
, Leica, Switzerland). Transverse sections were 
made from the polymerized blocks in the centre and at a 90° 
angle to the former drill hole defects. Grinding sections (30-
40 ?m) were surface stained with toluidine blue, while thin 
sections (5 ?m) were stained with toluidine blue and van 
Kossa/Mc Neal’s Tetrachrome. 
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2.5. Histomorphometry 
 The bone regeneration was quantitatively evaluated in the 
former drill hole defect area. Briefly, the grinding sections 
were read in a computer program (Leica IM 1000, Leica 
Microsystems, Switzerland) at a magnification of 12 by 
means of a macroscope (Leica
TM
 M420, Leica 
Microsystems) equipped with a digital camera (Leica
TM
 DFC 
320, Leica Microsytems). The margins of the cylindrical 
defects (diameter = 8 mm) were identified on the digital 
images. Then, the bone tissue within the defect area was 
marked (pixels) manually using commercial software 
(Adobe Photoshop) and a standardized computer macro was 
applied (Quips, QWin, Leica Microsystems) to detect areas 
of new bone formation. The percentage area fraction of new 
bone formation was calculated from the marked pixels and 
the total pixel number of the defect. 
2.6. Qualitative and Semi-Quantitative Evaluation 
 Thin histological sections were investigated with a 
microscope (DMR, Leica Microsystems) for semi-
quantitative and qualitative evaluation. The quality of new 
bone formation, resorption of bone cotton-wool and/or 
adjacent bone was assessed. The influences of silver 
containing material as well as signs of inflammation were 
indirectly recorded, such that cellular reactions were studied. 
A score system was applied to evaluate semi-quantitatively 
the cellular reactions in three different zones from the border 
to the centre of the former defect at a magnification of 400x 
(see Suppl. material 2). Macrophages, fibroblasts/fibrocytes 
and lymphocytes/plasma cells were assessed according to the 
percentage fraction of the cells per power field (score: 0 for 
0%, 1 for 1-25%, 2 for 26-50%, 3 for > 50%). Osteoclasts, 
foreign body giant cells (FBGC), circles of macrophages 
(macrophages arranged in circles around biomaterial but 
have not yet fused to FBGC) and bone islands (small areas 
of newly formed bone) were counted per power field (score: 
0 for none, 1 for 1-5, 2 for 6-10, 3 for > 11). 
2.7. Statistical Analysis 
 Statistical analysis using student t-test for independent 
values was carried out on histomorphometry (bone 
formation) and on the semi-quantitative (cell number, type 
and location) evaluation. The effect of silver on 
biocompatibility and bone formation was investigated in the 
two groups PLGA/CaP and PLGA/Ag-CaP. Results were 
considered to be significant at p < 0.05. 
3. RESULTS 
3.1. CaP and Ag-CaP nanoparticle preparation 
 CaP nanoparticles had a size of 20-50 nm and were 
optionally doped with silver (Ag-CaP) (Fig. 1a). The specific 
surface area of the CaP and Ag-CaP nanoparticles was 79 (± 
3%) m
2
/g and 73 (± 3%) m
2
/g, respectively. The amorphous 
state of the as-prepared nanoparticles was confirmed by X-
ray diffraction (XRD) patterns showing a broad 
characteristic peak at a 2? value of 31.0° (see Suppl. material 
1). Distinct patterns characteristic for crystalline ?-TCP were 
obtained after sintering at 900°C for 30 min and confirmed 
the chemically correct composition. The high phase purity of 
the nanoparticles was corroborated by FTIR-spectroscopy 
(see Suppl. material 1). Sintered powder showed 
characteristic peaks for ?-TCP whereas peaks for impurities 
such as pyrophosphate or IR peaks ascribed to OH-groups 
such as they exist in hydroxyapatite were not detected. The 
silver content in the Ag-CaP nanoparticles measured by atom 
absorption spectroscopy was 0.95 wt% and confirmed the 
reliability of the flame process in terms of silver 
incorporation. 
3.2. Bioactive, Flexible Nanocomposites (Bone Wool) 
 Scaffolds containing 40 wt% CaP or Ag-CaP in PLGA 
were prepared by low-temperature electrospinning. The as-
electrospun scaffolds could be manually transformed into a 
soft and compressible biomaterial with a cotton wool-like 
appearance (Fig. 1b). This flexible material allowed easy 
portioning and plugging in even complex shaped bone 
defects. The as-electrospun three-dimensional network 
consisted of homogenous fibres within a diameter range of 
5-10 ?m as shown by scanning electron microscopy. The 
fibres themselves were nanostructured due to the 
incorporated nanoparticles (Fig. 1c). The specific surface 
area of both fibrous scaffolds was 2 (± 3%) m
2
/g. 
 
Fig. (1). Characterisation of the materials. (a) Transmission electron microscopic image of as-prepared calcium phosphate nanoparticles. (b) 
Scaffolds in uncompressed form have a cotton wool-like appearance. (c) Scanning electron microscopic image of low-temperature 
electrospun PLGA/CaP 60:40 fibres showing a nanostructured surface (inlet). 
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3.3. Surgery in Sheep 
 The surgery of the two sheep was performed without 
complications. The handling of the electrospun PLGA/CaP 
and PLGA/Ag-CaP nanocomposites was straightforward and 
could be easily placed in the created drill hole defects (Fig. 
2). The packing density (180 mg/cm
3
) of the fibrous material 
was kept the same as in an earlier study in calvarial defects 
in rabbits [30]. Since this bone cotton wool is soft and 
flexible, there was no risk of damaging tissue when applying 
this artificial bone graft. Further, a proper adaptation to the 
bone defect was reached with this compressible material, 
which was also easily wetted with blood. Recovery from 
surgery went well for all sheep and wound healing was 
without complication, when skin staples were removed at 10 
days after surgery. 
3.4. Macroscopic and Radiographic Analysis 
 The scaffolds were well integrated in the original bone 
defects and covered with a layer of soft tissue at eight weeks 
after implantation. No signs of inflammatory reactions, such 
as necrosis or reddening suggesting implant rejection were 
found macroscopically. All originally created drill hole 
defects could be located radiographically except for one 
defect (humerus left proximal, filled with PLGA/CaP), 
which could not be found anymore. Microradiographs (see 
Suppl. material 3) showed bone formation inside the original 
defect and no signs of sclerosis within the adjacent bone. 
Calcification and new bone formation were in agreement 
with the ground sections, which were considered more 
appropriate to be used for quantitative evaluation of bone 
formation. 
3.5. Histomorphometry 
 The quantitative evaluation of bone formation was 
performed on the ground histological sections after surface  
 
staining with toluidine blue (Fig. 3). New bone formation 
(coloured in blue) was possible everywhere in the created 
circular defects. Since a clear differentiation between the 
remaining fibrous biomaterial and the granulation tissue was 
not possible, only the bone matrix was coloured in the 
original defect. The area fraction of newly formed bone for 
both materials is independent of the locations of the defect 
(Fig. 4). The average area of newly formed bone amounted 
to 20.5 ± 11.2 % for PLGA/CaP and 22.5 ± 9.2 % for 
PLGA/Ag-CaP treated defects. There was no statistically 
significant difference (p > 0.05) in bone formation for these 
two groups. The ratio between granulation tissue and 
remaining biomaterials was around 80:20 at two months 
after insertion of the implants. 
3.6. Qualitative and Semi-Quantitative Evaluation 
 The histological thin sections confirmed the 
biocompatibility of the bone substitutes and appeared the 
same for both electrospun scaffolds (Fig. 5). Both 
biomaterials were biocompatible and were mostly resorbed 
by macrophages, which were typically arranged as circles 
around the material (Fig. 5c). Bone islands were generally 
formed in regions where circles of macrophages were 
previously present (Fig. 5b). The cytoplasm of macrophages 
was loaded with material indicated through the typical 
birefringent appearance of polymers. The resorption zone 
was rich in cells and dominated by macrophages and 
osteoprogenitor cells (Fig. 5f). The active osteoid producing 
osteoblasts were not counted because they were abundant 
and always easily identified at the surface of the osteoid. At 
the investigated time period of eight weeks, only a few 
osteoclasts appeared and were found mostly at the calcified 
bone surface at the defect margins starting to remodel the 
newly formed woven bone. Blood vessels and erythrocytes 
were evenly distributed and followed the ossification front. 
No statistically significant differences could be found  
 
 
Fig. (2). Surgical procedure. (a, b) Filling of the drill hole defects (diameter = 8 mm, depth = 13 mm) in white Swiss Alpine sheep. The low-
temperature electrospun PLGA/CaP and PLGA/Ag-CaP scaffolds can be easily applied. 
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between the two groups PLGA/CaP 60:40 and PLGA/Ag-
CaP 60:40 regarding bone remodeling and cell types (Table 
1, Suppl. material 4) after eight weeks implantation. 
Fibroblasts and fibrocytes were found only in one defect 
with a percentage larger than 1% per power field. Overall, 
the presence of foreign body giant cells was low (1-5) and 
independent of location and group. Lymphocytes and plasma 
cells were generally low and equally distributed over the 
area, mostly close to vessels. They never appeared in clusters 
close to the material. Their distribution was similar as found 
in physiologic bone healing. 
4. DISCUSSION 
 The present in vivo performance of bone wool is based 
on earlier in vitro/in vivo studies [29, 30] optionally showing 
antimicrobial properties [31]. The here used protocol for 
biocompatibility and bone formation using drill hole defects 
in humerus and femur of Swiss Alpine sheep has been well 
established [32-34] since sheep are suitable for orthopaedic 
research due to a bone structure and metabolism comparable 
to humans [39]. Evaluation after eight weeks allows 
following cellular (bone formation) and inflammatory 
reactions. 
 
Fig. (3). Histological ground sections (surface stained with toluidine blue) after 8 weeks implantation of PLGA/CaP 60:40 (1
st 
and 4
th
 
column) and PLGA/Ag-CaP 60:40 (2
nd
 and 3
rd
 column) nanocomposites in (a) sheep 3118 and (b) sheep 3119. Formation of new bone (blue) 
is visible in the drill hole defects (diameter = 8 mm, depth = 13 mm). The ground section of sheep 3118 humerus left proximal is not 
available. 
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Fig. (4). Area fraction of newly formed bone within the original 
drill hole defect as a percentage of the total defect area. PLGA/CaP 
and PLGA/Ag-CaP scaffolds were implanted for eight weeks in 
distal epiphysis (di) and proximal metaphysis (pr) of the right (r) 
and left (l) humerus (hu) and femur (fe). 
Surgical Handling and Biocompatibility 
 The compressible, soft bone wool enabled convenient 
handling, fast manipulation by surgeons and complete 
contact between bone and implant (see Fig. 2). In the case of 
misplacement during surgical procedure, the scaffold could 
have been simply removed. The nanocomposites were 
biocompatible with surrounding tissue and no inflammatory 
reactions were observed (i.e. no fibrous encapsulation or 
implant rejection). A semi-quantitative score system was 
applied to describe the cellular reactions occurring at this 
stage of bone healing: Counting macrophages, foreign body 
giant cells, lymphocytes, plasma cells, fibrocytes and 
osteoclasts showed no statistically significant difference 
between bone wool with or without silver. The absence of 
clusters of lymphocytes, plasma cells and spindle type 
fibrocytes further confirmed biocompatibility. Materials 
were resorbed mostly through macrophages, arranged in 
circles in the resorption zone. Bone formation was mainly 
initiated by bone islands in regions where the biomaterial 
had previously been resorbed by phagocytosis. Additionally, 
bone formation was not negatively influenced by the 0.4 
wt% silver. A previous in vitro study had shown prolonged 
antimicrobial properties of silver containing bone wool 
against E. coli [31]. Hence, no specific tests on antimicrobial 
 
Fig. (5). Histological thin sections after 8 weeks implantation (representative for both nanocomposites, surface stained with van Kossa). (a, 
b) New bone is formed within the resorption zone (arrow). (c) Macrophages arranged in circles resorb the (d) biomaterial and (e) fuse finally 
to foreign body giant cells. The resorption zone consists further of (f) osteoprogenitor cells. The absence of clusters of lymphocytes, plasma 
cells and fibrocytes confirmed the biocompatibility of the electrospun PLGA/CaP and PLGA/Ag-CaP nanocomposites. 
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efficacy were included in order to not complicate the overall 
cellular picture. 
Bone Formation 
 The highly porous scaffolds enabled efficient cell 
ingrowth, which facilitated new bone formation everywhere 
in the former defect and additionally led to resorption of the 
biodegradable polymer fibres. Even within 8 weeks, bone 
formation was observed from the edge to the centre of the 
original defect (Fig. 6b, d). The fibres provided the 
necessary mechanical stability for mineralization and 
formation of cancellous bone. The necessity of filling drill 
hole defects with a bone graft has been shown in a recent 
study [33]. Defects left empty in the same defect model in 
sheep allowed only slow bone formation from the border of 
the former defects towards the centre: Histological 
investigations after two months implantation showed adipose 
cells in between newly formed bone and an organized blood 
clot in the centre of the defect (Fig. 6a). With increasing 
implantation time, the blood clot was resorbed and replaced 
by adipose and fibrous tissue containing predominantly 
fibrocytes. This resulted in bone resorption after four months 
implantation (Fig. 6c). The percentages of new bone matrix 
for empty defects increased from the 2
nd
 month (43.2 %) to 
the 4
th
 month (58.6 %) but decreased then to 27.3 % after six 
months implantation (Table 2). PLGA/CaP and PLGA/Ag-
CaP treated defects showed newly formed bone after two 
months implantation with an area fraction of 20.5 % and 
22.5 %, respectively. However, bone formation is expected 
to continue throughout the defect after two months 
implantation as there were no signs of cellular reactions, 
which would influence the bone healing negatively. 
Moreover, histological evaluation showed regions with 
tissue that will induce shortly endochondral ossification and 
will become bone tissue. 
Comparison of Bone Cotton Wool to Other Bone 
Substitutes 
 The use of this cotton wool-like biomaterial is beneficial 
for bone regeneration compared to other rigid implant 
materials. In a recent study by Schneider et al. [30], 
PLGA/CaP 60:40 nanocomposites were used to treat circular 
defects (diameter = 6 mm) in the cranium of New Zealand 
White rabbits. There, the percentage of newly formed bone 
after four weeks implantation was significantly improved for 
CaP containing fibres (34.9 ± 17.0 %) if compared to pure 
PLGA fibres (25.1 ± 14.6 %). Therefore, pure PLGA fibres 
were not included within the present study. The bone 
regeneration was more advanced after four weeks 
implantation in the rabbit than after eight weeks implantation 
in sheep, demonstrating that bone formation is difficult to 
compare in between different defect models and animals. For 
this reason, the performance of the bone cotton wool-like 
material is compared with other artificial bone substitutes in 
the same defect model in sheep. Commercially available and 
injectable calcium phosphate cements assessed in sheep for 
two months resulted in similar area fractions of new bone 
(18.0 % for Norian SRS
®
 and 24.8 % for chronOS Inject
TM
) 
[33] as obtained with the PLGA/CaP nanocomposites (Table 
2). However, even though the brushite cement (chronOS 
Inject
TM
) resorbed faster than the apatite cement (Norian 
SRS
®
), new bone formation was not observed in the centre 
of the defect and was controlled through the resorption front. 
The resorption of the brushite cement occurred mainly 
through macrophages in a similar way as observed for the 
PLGA/CaP nanocomposites. Porous ?-TCP blocks [34] 
investigated in the same sheep model showed within the first 
six weeks implantation faster resorption of the material than 
formation of new bone (12.8 % for blocks with pore 
diameter of 260 ?m). Only few newly formed bone tissue 
was histomorphometrically observed in the centre of the 
Table 1. Semi-Quantitative Analysis of Biocompatibility and Bone Formation After 8 Weeks Implantation Applying a Score 
System in Three Different Zones from the Border Towards Centre of the Former Defect 
 
Variable  Group  Zone 1  Zone 2  Zone 3  Total  
PLGA/CaP  0.3 ± 0.5  0.3 ± 0.5  0.1 ± 0.4  0.7 ± 0.5  
Lymphocytes/plasma cellsa  
PLGA/Ag-CaP  0.3 ± 0.5  0.1 ± 0.4  0.0 ± 0.0  0.4 ± 0.7  
PLGA/CaP  1.0 ± 0.0  1.1 ± 0.4  1.1 ± 0.4  3.3 ± 0.8  
Macrophagesa  
PLGA/Ag-CaP  1.1 ± 0.4  0.9 ± 0.4  0.9 ± 0.4  2.9 ± 0.8  
PLGA/CaP  0.0 ± 0.0  0.1 ± 0.4  0.0 ± 0.0  0.1 ± 0.4  
Fibroblasts/fibrocytesa  
PLGA/Ag-CaP  0.0 ± 0.0  0.0 ± 0.0  0.0 ± 0.0  0.0 ± 0.0  
PLGA/CaP  0.0 ± 0.0  0.3 ± 0.5  0.3 ± 0.5  0.6 ± 0.8  
Foreign body giant cellsb  
PLGA/Ag-CaP  0.3 ± 0.5  0.5 ± 0.5  0.3 ± 0.5  1.0 ± 0.9  
PLGA/CaP  0.3 ± 0.5  0.9 ± 0.4  0.7 ± 0.5  1.9 ± 0.9  
Macrophages circlesb  
PLGA/Ag-CaP  0.6 ± 0.7  0.8 ± 0.7  0.8 ± 0.5  2.1 ± 1.5  
PLGA/CaP  0.3 ± 0.5  0.9 ± 0.4  0.4 ± 0.5  1.6 ± 0.8  
Bone islandsb  
PLGA/Ag-CaP  0.6 ± 0.5  0.8 ± 0.4  0.3 ±0 .5  1.6 ± 0.9  
PLGA/CaP  0.4 ± 0.5  0.1 ± 0.4  0.1 ± 0.4  0.7 ± 1.0  
Osteoclastsb  
PLGA/Ag-CaP  0.8 ± 0.5  0.3 ± 0.5  0.0 ± 0.0  1.0 ± 0.8  
aScores (0 for 0%, 1 for 1-25%, 2 for 26-50%, 3 for > 50%) for percentage fraction of the cells per power field and the corresponding sum for each cell type. 
bScores (0 for none, 1 for 1-5, 2 for 6-10, 3 for > 11) for the absolute number of the cells per power field and the corresponding sum for each cell type. 
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defect, which may be attributed to the only partly available 
interconnected pores. However, the porous ?-TCP blocks 
would enable mechanical loading in the defect right from the 
start, which can not be said for the here applied 
nanocomposites. 
5. CONCLUSIONS 
 The easy applicable cotton wool-like material suggests 
application for non-load bearing complex shaped bone 
defects. The advantageous use of this compressible material 
would be foreseen generally to be valuable in minimally 
invasive surgery or for specific indications in dental surgery 
(i.e. sinus augmentation, augmentation procedures of the 
alveolar bone, socket preservation after tooth extraction) 
where the antimicrobial properties of PLGA/Ag-CaP could 
be beneficial. Before testing this cotton wool-like material in 
humans, further investigations in animals are necessary to 
evaluate bone regeneration over a longer time period. 
ACKNOWLEDGEMENT 
 Financial support by ETH Zurich is kindly acknowledged. 
 
Fig. (6). Bone formation in defects left empty and for bone cotton wool treated defects. Histological ground sections for (a) empty defect 
shows the formation of an organized blood clot in the centre of defect whereas for (b) PLGA/CaP treated defect bone formation (blue) is 
visible. Schematic description (c, d) of bone formation (red arrow) and bone resorption (black arrow). 
Table 2. Area Fraction of Newly Formed Bone After Implantation of Different Materials in Created Circular (Diameter = 8 mm, 
Depth = 13 mm) Defects in Long Bone of Sheep 
 
Material  Implantation Time/Months  Newly Formed Bone/%  
PLGA/CaP 60:40  2  20.5  
PLGA/Ag-CaP 60:40  2  22.5  
Norian SRS a  2  18.0  
chronOS Inject® a  2  24.8  
Porous ?-TCP blocksb  1.5  12.8  
Defect left emptya  2  43.2  
Defect left emptya  4  58.6  
Defect left emptya  6  27.3  
aResults adopted from the study by Apelt et al. [33]. 
bResults adopted from the study by von Doernberg et al. [34]. 
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SUPPLEMENTARY INFORMATION 
 This article contains supplementary material that can be 
viewed at publisher’s website. 
 Suppl. material 1: Preparation and characterisation of 
cotton wool-like PLGA/CaP nanocomposites including 
flame spray synthesis of CaP nanoparticles. 
 Suppl. material 2: Schematic description of the 
investigated zones in the former defect for semi-quantitative 
histological evaluation. 
 Suppl. material 3: Microradiographs after eight weeks 
implantation. 
 Suppl. material 4: Semi-quantitative analysis of the 
cellular content after eight weeks implantation of bone 
cotton wool and applying a score system. 
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